Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.24.1.u1
Condensed Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Revenues:        
Total revenues $ 2,359,830 $ 2,432,608 $ 7,243,512 $ 8,140,919
Costs and expenses:        
Costs of revenues 993,885 1,005,346 2,917,522 3,255,358
Research and development 321,590 328,276 953,222 979,617
Selling, general and administrative 237,514 238,393 714,403 735,469
Impairment of goodwill and purchased intangible assets 70,474 0 289,474 0
Interest expense 79,981 74,774 228,417 223,449
Loss on extinguishment of debt 0 0 0 13,286
Other expense (income), net (45,622) (14,864) (104,515) (79,944)
Income before income taxes 702,008 800,683 2,244,989 3,013,684
Provision for income taxes 100,467 102,846 319,539 310,987
Net income 601,541 697,837 1,925,450 2,702,697
Less: Net income attributable to non-controlling interest 0 0 0 74
Net income attributable to KLA $ 601,541 $ 697,837 $ 1,925,450 $ 2,702,623
Net income per share attributable to KLA        
Basic (in dollars per share) $ 4.46 $ 5.06 $ 14.20 $ 19.26
Diluted (in dollars per share) $ 4.43 $ 5.03 $ 14.11 $ 19.16
Weighted-average number of shares:        
Basic (in shares) 134,954 137,865 135,638 140,349
Diluted (in shares) 135,856 138,645 136,428 141,073
Product        
Revenues:        
Total revenues $ 1,769,369 $ 1,903,484 $ 5,527,842 $ 6,562,501
Service        
Revenues:        
Total revenues $ 590,461 $ 529,124 $ 1,715,670 $ 1,578,418